Zobrazeno 1 - 10
of 170
pro vyhledávání: '"F. Ghilardi"'
Autor:
E. Tatti, F. Ferraioli, J. Peter, T. Alalade, A. B. Nelson, S. Ricci, A. Quartarone, M. F. Ghilardi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Movement is accompanied by beta power changes over frontal and sensorimotor regions: a decrease during movement (event-related desynchronization, ERD), followed by an increase (event-related synchronization, ERS) after the movement end. We p
Externí odkaz:
https://doaj.org/article/04f869e0f48a4829baafc5025209897d
Autor:
Mary E. Law, Bradley J. Davis, Amanda F. Ghilardi, Elham Yaaghubi, Zaafir M. Dulloo, Mengxiong Wang, Olga A. Guryanova, Coy D. Heldermon, Stephan C. Jahn, Ronald K. Castellano, Brian K. Law
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Tranexamic Acid (TA) is a clinically used antifibrinolytic agent that acts as a Lys mimetic to block binding of Plasminogen with Plasminogen activators, preventing conversion of Plasminogen to its proteolytically activated form, Plasmin. Previous stu
Externí odkaz:
https://doaj.org/article/5f7f9ec5aa3941a2b5245b8c17992f04
Autor:
E. Tatti, F. Ferraioli, J. Peter, T. Alalade, A. B. Nelson, S. Ricci, A. Quartarone, M. F. Ghilardi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/4bd91bbe559441e58db043656cb8bd7f
Autor:
Elisa Tatti, Serena Ricci, Ramtin Mehraram, Nancy Lin, Shaina George, Aaron B. Nelson, Maria F. Ghilardi
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 13 (2019)
Beta power over the sensorimotor areas starts decreasing just before movement execution (event-related desynchronization, ERD) and increases post-movement (event-related synchronization, ERS). In this study, we determined whether the magnitude of bet
Externí odkaz:
https://doaj.org/article/eea6e9b6d42b4d788fb218c5d001dc50
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amanda F. Ghilardi, Elham Yaaghubi, Renan B. Ferreira, Mary E. Law, Yinuo Yang, Bradley J. Davis, Christopher M. Schilson, Ion Ghiviriga, Adrian E. Roitberg, Brian K. Law, Ronald K. Castellano
Publikováno v:
ChemMedChem. 17(14)
Reported are structure-property-function relationships associated with a class of cyclic thiosulfonate molecules-disulfide-bond disrupting agents (DDAs)-with the ability to downregulate the Epidermal Growth Factor Receptor (HER) family in parallel an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9299246f4cb75a37a40561cb1fc958
https://pubmed.ncbi.nlm.nih.gov/35491396
https://pubmed.ncbi.nlm.nih.gov/35491396
Autor:
Mary E. Law, Chi Wu Chiang, Sadie F. DePeter, Elham Yaaghubi, Sixue Chen, Peter Nørgaard, Bradley J. Davis, Christopher M. Schilson, Ronald K. Castellano, Brian K. Law, Renan B. Ferreira, Jin Koh, Coy D. Heldermon, Amanda F. Ghilardi
Publikováno v:
Law, M E, Yaaghubi, E, Ghilardi, A F, Davis, B J, Ferreira, R B, Koh, J, Chen, S, DePeter, S F, Schilson, C M, Chiang, C W, Heldermon, C D, Nørgaard, P, Castellano, R K & Law, B K 2022, ' Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death ', Cancer Letters, vol. 534, 215604 . https://doi.org/10.1016/j.canlet.2022.215604
Breast cancer mortality remains unacceptably high, indicating a need for safer and more effective therapeutic agents. Disulfide bond Disrupting Agents (DDAs) were previously identified as a novel class of anticancer compounds that selectively kill ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29acbb40a00907464bfc8ac10a6fd1a2
https://curis.ku.dk/ws/files/358644313/2021.01.13.426390v3.full.pdf
https://curis.ku.dk/ws/files/358644313/2021.01.13.426390v3.full.pdf
Publikováno v:
Communications in Computer and Information Science ISBN: 9783030944254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52d19a5566e76987f4ddb67725b66ff7
http://hdl.handle.net/2318/1834882
http://hdl.handle.net/2318/1834882
Autor:
Mary E. Law, Brian K. Law, Ronald K. Castellano, Renan B. Ferreira, Mengxiong Wang, Bradley J. Davis, Elham Yaaghubi, Amanda F. Ghilardi, Chi Wu Chiang, Olga A. Guryanova, Coy D. Heldermon, Daniel Kopinke
Publikováno v:
Cell Death Discovery, Vol 5, Iss 1, Pp 1-15 (2019)
Cell Death Discovery
Cell Death Discovery
Disulfide bond-disrupting agents (DDAs) are a new chemical class of agents recently shown to have activity against breast tumors in animal models. Blockade of tumor growth is associated with downregulation of EGFR, HER2, and HER3 and reduced Akt phos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e52dcc29392ea12d61f42e6a1a07290
http://link.springer.com/article/10.1038/s41420-019-0228-9
http://link.springer.com/article/10.1038/s41420-019-0228-9
Autor:
Coy D. Heldermon, Mary Elizabeth Law, Mengxiong Wang, Z. M. Dulloo, Brian K. Law, Ronald K. Castellano, Olga A. Guryanova, Elham Yaaghubi, Bradley J. Davis, Amanda F. Ghilardi
Tranexamic Acid (TA) is a clinically used antifibrinolytic that acts as a lysine mimetic to block binding of Plasminogen with Plasminogen activators, preventing conversion of Plasminogen to its proteolytically activated form, Plasmin. Previous studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30e9d3507b20c68b9dc3d36ae9b0954b
https://doi.org/10.1101/2021.10.17.464714
https://doi.org/10.1101/2021.10.17.464714